Pacific Shuanglin Bio pharmacy Co Ltd (000403) — Cash Flow-to-Debt Ratio
Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥70.28 Million could theoretically repay 0% of its total liabilities (CN¥1.55 Billion) in one year. See financial flexibility index of Pacific Shuanglin Bio pharmacy Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pacific Shuanglin Bio pharmacy Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Pacific Shuanglin Bio pharmacy Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see Pacific Shuanglin Bio pharmacy Co Ltd cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Pacific Shuanglin Bio pharmacy Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Pacific Shuanglin Bio pharmacy Co Ltd. Check 000403 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.16x | CN¥-215.99 Million | CN¥1.39 Billion | ▼ -164.4% |
| 2024 | 0.24x | CN¥321.79 Million | CN¥1.33 Billion | ▼ -56.9% |
| 2023 | 0.56x | CN¥679.01 Million | CN¥1.21 Billion | ▲ +20.2% |
| 2022 | 0.47x | CN¥524.22 Million | CN¥1.12 Billion | ▼ -12.9% |
| 2021 | 0.54x | CN¥408.22 Million | CN¥760.07 Million | ▲ +89.0% |
| 2020 | 0.28x | CN¥194.84 Million | CN¥685.71 Million | ▼ -30.0% |
| 2019 | 0.41x | CN¥190.84 Million | CN¥470.04 Million | ▲ +143.0% |
| 2018 | 0.17x | CN¥116.63 Million | CN¥698.08 Million | ▲ +454.4% |
| 2017 | -0.05x | CN¥-35.91 Million | CN¥761.70 Million | ▼ -152.5% |
| 2016 | 0.09x | CN¥62.49 Million | CN¥696.41 Million | ▼ -5.6% |
| 2015 | 0.10x | CN¥70.31 Million | CN¥739.82 Million | ▼ -9.3% |
| 2014 | 0.10x | CN¥77.04 Million | CN¥735.16 Million | ▼ -3.8% |
| 2013 | 0.11x | CN¥91.01 Million | CN¥835.47 Million | ▼ -31.0% |
| 2012 | 0.16x | CN¥123.24 Million | CN¥780.27 Million | ▼ -17.7% |
| 2011 | 0.19x | CN¥130.14 Million | CN¥678.06 Million | ▲ +1165.7% |
| 2010 | 0.02x | CN¥9.88 Million | CN¥651.42 Million | ▼ -84.9% |
| 2009 | 0.10x | CN¥111.86 Million | CN¥1.11 Billion | ▲ +39.1% |
| 2008 | 0.07x | CN¥74.90 Million | CN¥1.04 Billion | ▲ +25.3% |
| 2007 | 0.06x | CN¥95.03 Million | CN¥1.65 Billion | ▲ +1058.2% |
| 2006 | -0.01x | CN¥-10.42 Million | CN¥1.73 Billion | ▼ -124.1% |
| 2005 | 0.02x | CN¥49.06 Million | CN¥1.97 Billion | ▲ +128.6% |
| 2004 | -0.09x | CN¥-131.73 Million | CN¥1.51 Billion | ▼ -146.5% |
| 2003 | -0.04x | CN¥-49.47 Million | CN¥1.40 Billion | ▼ -117.0% |
| 2002 | 0.21x | CN¥159.18 Million | CN¥765.52 Million | ▲ +29.1% |
| 2001 | 0.16x | CN¥111.28 Million | CN¥690.82 Million | ▲ +241.0% |
| 2000 | 0.05x | CN¥27.36 Million | CN¥579.29 Million | ▲ +198.0% |
| 1999 | -0.05x | CN¥-23.08 Million | CN¥478.92 Million | ▼ -424.9% |
| 1998 | -0.01x | CN¥-2.65 Million | CN¥288.28 Million | — |